Virtual and Physical Health Assessments and Treatment Plans (VHAT)
March 24, 2026 updated by: CAMC Health System
Comparison of Virtual to Physical Health Assessments and Treatment Plans for Patients Presenting for Initial Vascular Clinic Visits
The aim of the current study is to compare virtual clinic visits (i.e., real-time, face-to-face visits conducted over the internet with tablet devices) to actual physical clinic visits.
After both types of visits (virtual versus physical) physicians will be asked to classify patients into low, moderate or high risk for a vascular intervention.
It is hypothesized that there will be good agreement between classifications made after the virtual visits as compared to those made after physical visits.
That is, virtual visit classifications will be as good as those made after physical visits.
Study Overview
Detailed Description
Patient dissatisfaction can increase because of the complexities associated with navigating modern health care systems.
It is easy to speculate that some of this dissatisfaction is associated with travel, wait times and other issues that arise during routine clinic visits.
The authors of recent studies have demonstrated that it is possible and feasible to conduct many routine visits remotely.
It is our belief that virtual health assessments and treatment plans (VHAT) conducted remotely can be as effective, perhaps be more efficient and increase patient satisfaction when compared to regular physical health assessments and treatment plans (PHAT).
Physicians want to provide optimal health care; however, in geographically isolated areas such as some locations in West Virginia that can be a challenge.
It seems reasonable to believe that monitoring patients with telehealth technology, collecting on-going real time data and conducting VHAT can provide high quality health care for patients.
It can also help to classify health risk, increase patient and medical staff satisfaction, decrease staff time for visits, while at the same time increase the efficiency of the follow-up process.
The investigators plan to compare the physician assessments and future treatment plans made using VHAT to those made after PHAT.
It is believed that VHAT assessments will be in agreement with those made with PHAT.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Charleston, West Virginia, United States, 25304
- CAMC Health Education and Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-Patients referred to and scheduled for an initial visit at our Vascular Center of Excellence (VCOE).
Exclusion Criteria:
- Patients that are deemed urgent cases by the VCOE, and scheduled within two weeks for the initial clinic visit.
- Patients who are scheduled to have the placement of an arteriovenous (AV) fistula at the time of the initial clinic visit.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Type of visit
Single arm, non-randomized crossover design.
All patients will receive both types of visits virtual and physical, and after assessments are made, participants will be classified by physicians into low, moderate or high risk for intervention.
|
Type of visit
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Categorization of physician treatment plans. (Physicians will classify treatment plans as low, moderate or high need for vascular intervention)
Time Frame: 1 week
|
Comparison of virtual visit treatment plans to physical treatment plans.
After assessments, physicians will classify patients' treatment plans into low (treat medically), moderate (vascular intervention in the future, but not immediately) or high (needs immediately, within 2 weeks).
The distribution of low, moderate and high among the two types of visits (Virtual and Physical) will be compared.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: 1 week
|
Comparison of patient satisfaction after virtual and physical visits.
Satisfaction will be measured by two survey questions based on a 1 to 5 Likert scale.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 4, 2019
Primary Completion (Actual)
February 28, 2022
Study Completion (Actual)
February 28, 2022
Study Registration Dates
First Submitted
April 12, 2019
First Submitted That Met QC Criteria
May 9, 2019
First Posted (Actual)
May 13, 2019
Study Record Updates
Last Update Posted (Actual)
March 27, 2026
Last Update Submitted That Met QC Criteria
March 24, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-558
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.